Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
12.53
+1.04 (9.05%)
At close: Jun 3, 2026, 4:00 PM EDT
12.56
+0.03 (0.24%)
After-hours: Jun 3, 2026, 4:31 PM EDT
Elicio Therapeutics Employees
Elicio Therapeutics had 33 employees as of December 31, 2025. The number of employees increased by 1 or 3.13% compared to the previous year.
Employees
33
Change (1Y)
1
Growth (1Y)
3.13%
Revenue / Employee
n/a
Profits / Employee
-$1,217,727
Market Cap
230.50M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 33 | 1 | 3.13% |
| Dec 31, 2024 | 32 | 0 | - |
| Dec 31, 2023 | 32 | 9 | 39.13% |
| Dec 31, 2022 | 23 | -1 | -4.17% |
| Dec 31, 2021 | 24 | 2 | 9.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| Voyager Therapeutics | 141 |
| Arcturus Therapeutics Holdings | 111 |
| Nkarta | 108 |
| Alector | 103 |
| Orchestra BioMed Holdings | 86 |
| Sol-Gel Technologies | 28 |
| Whitehawk Therapeutics | 23 |
ELTX News
- 2 days ago - Elicio Therapeutics publishes data on AMP-DNA adjuvant technology - TheFly
- 2 days ago - Elicio Therapeutics Announces Publication in Peer-Reviewed Journal Science Advances Highlighting Potent and Durable Immune Responses Driven by Company's AMP-DNA Adjuvant Technology - GlobeNewsWire
- 20 days ago - Elicio Therapeutics Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 23 days ago - Elicio Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 23 days ago - Elicio Therapeutics Earnings release: Q1 2026 - Filings
- 23 days ago - Elicio Therapeutics Quarterly report: Q1 2026 - Filings
- 4 weeks ago - Elicio Therapeutics to Present at the Bank of America Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Elicio Therapeutics Reports Inducement Grants - GlobeNewsWire